Literature DB >> 31056356

Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.

Carrie B Moore1, Morgan L Cox2, Michael S Mulvihill2, Jacob Klapper3, Thomas A D'Amico3, Matthew G Hartwig3.   

Abstract

OBJECTIVE: The objective of this project was to assess the best measure for postoperative outcomes by comparing 30-day and 90-day mortality rates after surgery for non-small cell lung cancer using the National Cancer Database. Secondarily, hospital performance was examined at multiple postoperative intervals to assess changes in ranking based on mortality up to 1 year after surgery.
METHODS: Patients who had undergone surgery for non-small cell lung cancer between 2004 and 2013 were identified in the National Cancer Database. Mortality rates at 30 days and 90 days were compared after adjusting for several patient characteristics, tumor variables, and hospital procedural volume using generalized logistic mixed models. Subsequently, mixed model logistic regression models were employed to evaluate hospital performance based on calculated mortality at prespecified time points.
RESULTS: A total of 303,579 patients with non-small cell lung cancer were included for analysis. The 90-day mortality was almost double the 30-day mortality (3.0% vs 5.7%). Several patient characteristics, tumor features, and hospital volume were significantly associated with mortality at both 30 days and 90 days. Hospital rankings fluctuate appreciably between early mortality time points, which is additional evidence that quality metrics need to be based on later mortality time points.
CONCLUSIONS: Thirty-day mortality is the commonly accepted quality measure for thoracic surgeons; however, hospital rankings may be inaccurate if based on this variable alone. Mortality after 90 days appears to be a threshold after which there is less variability in hospital ranking and should be considered as an alternative quality metric in lung cancer surgery.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  30-day mortality; 90-day mortality; National Cancer Database (NCDB); hospital ranking; lung cancer surgery; quality metrics

Mesh:

Year:  2019        PMID: 31056356     DOI: 10.1016/j.jtcvs.2019.02.123

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  2 in total

1.  Time-varying analysis of readmission and mortality during the first year after pneumonectomy.

Authors:  Gregory D Jones; Kay See Tan; Raul Caso; Joseph Dycoco; Bernard J Park; Matthew J Bott; Daniela Molena; James Huang; James M Isbell; Manjit S Bains; David R Jones; Gaetano Rocco
Journal:  J Thorac Cardiovasc Surg       Date:  2020-03-07       Impact factor: 5.209

2.  Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?

Authors:  Hai Tang; Yijiu Ren; Yunlang She; Chenyang Dai; Tingting Wang; Hang Su; Weiyan Sun; Gening Jiang; Chang Chen
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.